| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |